These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19944971)

  • 1. Heat shock proteins in glioblastomas.
    Yang I; Fang S; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein-peptide complex in the treatment of glioblastoma.
    See AP; Pradilla G; Yang I; Han S; Parsa AT; Lim M
    Expert Rev Vaccines; 2011 Jun; 10(6):721-31. PubMed ID: 21692695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination.
    Wheeler CJ; Das A; Liu G; Yu JS; Black KL
    Clin Cancer Res; 2004 Aug; 10(16):5316-26. PubMed ID: 15328167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein vaccines against glioblastoma: from bench to bedside.
    Ampie L; Choy W; Lamano JB; Fakurnejad S; Bloch O; Parsa AT
    J Neurooncol; 2015 Jul; 123(3):441-8. PubMed ID: 26093618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastoma-derived mechanisms of systemic immunosuppression.
    Waziri A
    Neurosurg Clin N Am; 2010 Jan; 21(1):31-42. PubMed ID: 19944964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors].
    Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H
    Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein vaccines: from bench to bedside.
    Binder RJ
    Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.
    Murshid A; Gong J; Calderwood SK
    Expert Rev Vaccines; 2008 Sep; 7(7):1019-30. PubMed ID: 18767951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of heat shock proteins in tumor immunity.
    Li Z
    Cancer Chemother Biol Response Modif; 2001; 19():371-83. PubMed ID: 11686024
    [No Abstract]   [Full Text] [Related]  

  • 10. Heat-shock protein vaccines as active immunotherapy against human gliomas.
    Yang I; Han S; Parsa AT
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1577-82. PubMed ID: 19895242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock protein-based cancer vaccines.
    Oki Y; Younes A
    Expert Rev Vaccines; 2004 Aug; 3(4):403-11. PubMed ID: 15270645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.
    Khansur E; Shah AH; Lacy K; Komotar RJ
    Cancer Invest; 2019; 37(1):1-7. PubMed ID: 30632816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current ideas about applications of heat shock proteins in vaccine design and immunotherapy.
    Wang XY; Li Y; Yang G; Subjeck JR
    Int J Hyperthermia; 2005 Dec; 21(8):717-22. PubMed ID: 16338854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine for aggressive brain tumors may prolong survival.
    Health News; 2004 Dec; 10(12):7. PubMed ID: 15645564
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R; Itoh K
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial.
    Bloch O; Crane CA; Fuks Y; Kaur R; Aghi MK; Berger MS; Butowski NA; Chang SM; Clarke JL; McDermott MW; Prados MD; Sloan AE; Bruce JN; Parsa AT
    Neuro Oncol; 2014 Jan; 16(2):274-9. PubMed ID: 24335700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chaperone therapy in the rat model of intracranial glioblastoma].
    Shevtsov MA; Kharatrian VA; Pozdniakov AV; Romanova IV; Guzhova IV; Margulis BA
    Vopr Onkol; 2012; 58(5):653-7. PubMed ID: 23600283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunizations with IFNgamma secreting tumor cells can eliminate fully established and invasive rat gliomas.
    Janelidze S; Bexell D; Badn W; Darabi A; Smith KE; Fritzell S; Gunnarsson S; Milos P; Bengzon J; Salford LG; Siesjö P; Visse E
    J Immunother; 2009; 32(6):593-601. PubMed ID: 19483650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Immunotherapy for Glioblastoma Multiforme.
    Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X
    J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock proteins as vaccine adjuvants in infections and cancer.
    Segal BH; Wang XY; Dennis CG; Youn R; Repasky EA; Manjili MH; Subjeck JR
    Drug Discov Today; 2006 Jun; 11(11-12):534-40. PubMed ID: 16713905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.